University of Lethbridge researching possible Parkinson’s disease treatments

The University of Lethbridge has been chosen to research GB Sciences' new patent-protected formulations of a potential Parkinson’s disease (PD) treatment.
Led by Dr. Robert Sutherland, the study will focus on the cannabis-based formulations as a way to potentially slow down or possibly reverse the symptoms of PD.
One cause of PD is the death of nerve cells in the basal ganglia. This area of the brain controls bodily movement, and the cells that die are dopamine-producing cells. The lack of dopamine produced by the basal ganglia results in some of the common symptoms, like shakiness, difficulty with coordination and balance issues.
Another cause is the death of nerve endings that produce norepinephrine, the main chemical messenger of the nervous system. This results in other symptoms, like fatigue, irregular blood pressure, and decreased movement of food through the digestive tract.
Sutherland says the causes of PD make it difficult to treat, but he is hoping this study will be a breakthrough in potential treatments.
"Right now there’s no cure for Parkinson’s disease, there’s no treatment that even slows down the process significantly and that’s an important fact," Sutherland said.
"It’s the second most common neurodegenerative disorder after Alzheimer’s disease. So finding anything that produces a benefit or could actually pause the disease progression is really significant."
The cannabis-based formulations don’t have any THC or other psychoactive chemicals in them. Rather than trying to mimic dopamine, it hopes to protect the dopamine producing cells.
"There is no direct dopamine effect, so these cannabinoids do not mimic dopamine, but they do tend to have a neuroprotectant function. So there’s an endogenous process inside the brain of people with Parkinson’s Disease that slowly kills off the dopamine neurons and it’s thought that these mixtures will actually block or interfere with that killing off of the dopamine neurons," Sutherland says.
While the formulation is expected to protect these neurons, it’s possible that it could even help dying cells recover.
"There’s a little bit of residual capacity in these dopamine neurons to recover from damage, and a second possible mechanism of action is that these compounds actually stimulate recovery of dopamine neurons. So as well as being protective, they may actually increase the health of dopamine neurons that are remaining," Sutherland says.
Dopamine and norepinephrine neurons share many similarities, so it’s possible that the formulations could impact both leading causes of PD.
"There’s a lot of similarities between dopamine neurons and norepinephrine neurons neurochemically. They resemble each other. So there’s a good possibility that this would be neuroprotective or reverse the symptoms of norepinephrine loss as well," Sutherland says.
Ultimately, the main goal of the study is to put the brakes on PD progression, and to reverse some of the symptoms.
"The main point is to make sure we can reverse these symptoms. So can we actually restore normal movement functions? That’s goal number one," Sutherland says.
The study began last week, and is divided into three steps:
- Test the correct dosage range of the formulation with normal mice. This is a dose-response experiment where they apply three different doses to mice and continuously monitor their behavior under the influence of the formulation. This is to make sure there aren’t any serious side effects.
- After finding the correct dosage, apply it to mice that have a form of experimental PD. This is to see if it improves their movement, and whether or not the mixtures in the appropriate dose can restore some function.
- Testing if the formulation can block the death of dopamine neurons in mice. On top of that, they will also see if it’s possible to reverse symptoms.
Currently, the study is in the early stages of the first steps.
CTVNews.ca Top Stories

Monster storm in North Atlantic stretches cloud from Atlantic Canada to Portugal
A large low-pressure system centred about 750 kilometres to the northeast of Newfoundland is causing clouds to stretch all the way to Portugal.
'Trudeau can end it all': Conservative carbon tax filibuster stretches into second night
With no signs either side is ready to retreat, the marathon voting session in the House of Commons has stretched into its second day, after MPs stayed up all night rejecting Conservative attempts to defeat government spending plans over the Liberals' refusal to scrap the carbon tax.
Shohei Ohtani watch kicks into higher gear in Toronto as Blue Jays fans track private plane
Shohei Ohtani watch in Toronto has kicked into another gear.
Canadian alleges discrimination, sues federal government in effort to get grandchildren out of Gaza
A Palestinian-Canadian is suing the federal government in an effort to get his four grandchildren out of Gaza. Mohammed Nofal, 74, is alleging Global Affairs Canada and immigration officials created a discriminatory policy that denied his family help in evacuating a war zone in the days following the Oct. 7 Hamas attack on Israel.
'We're inside the patient, looking directly at the tumour': Gaming experience aids surgery
An Ontario teen is among the first patients in the country to have a rare type of cancer surgically removed by doctors who trained using a virtual reality system that allows them to 'walk' inside a patient's body.
'Pseudoscience': Alberta's health minister under fire for naturopathic medicine meeting
Alberta's health minister is facing pushback after taking a meeting focused on naturopathic medicine's role in the province's primary care.
2 Ontario men charged after allegedly producing recruitment videos for listed terrorist entity
Two men from Ontario have been arrested on charges of terrorism after allegedly producing recruitment videos for a listed terrorist organization and circulating far-right manifestos online, police say.
1 in 9 Canadian adults have had long-term symptoms from COVID infection: StatCan
About one in nine Canadian adults have had long-term symptoms from COVID-19 infection, according to a Statistics Canada report issued Friday.
Pompeii archaeologists uncover bakery that doubled as a prison
An ancient bakery operated by slaves has been discovered in the ruins of Pompeii, the Pompeii Archaeological Park said in a statement released Friday.